WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr | ₹-3.36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-5.50 Cr |
Mar2023 | ₹-5.50 Cr |
Mar2022 | ₹-5.63 Cr |
Mar2021 | ₹-5.63 Cr |
Mar2020 | ₹-3.36 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.50 Cr | Negative | |
Mar2023 | ₹-5.50 Cr | Negative | |
Mar2022 | ₹-5.63 Cr | Negative | |
Mar2021 | ₹-5.63 Cr | Negative | |
Mar2020 | ₹-3.36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹910.5 Cr | -4.4% | 4.8% | 20.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -4.4% |
4.8% |
20.8% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses